Gene: [13q34/F7] coagulation factor VII (serum prothrombin conversion accelerator); hypoproconvertinemia (factor VII deficiency);

GEN

[1] The gene length is 12.8 kb. Exons: 9 (1a= 110 bp, 1b= 66, 2= 161, 3= 25, 4= 139, 5= 141, 6= 110, 7= 124, 8= 1600); introns: 8 (A1=1067 bp, A2= 2574, B= 1919, C= 68, D= 1908, E= 971, F= 595, G= 816). Exons 1a and 1b, as well as a 5'-third of exon 2 code for preproleader peptide. Exon 1b is facultative; it is able to be processed along with flanking introns thus determining signal peptide length polymorphism. Normal liver mRNA is enriched with a shorter transcript, which does not contain exon 1b (coding for a 22-amino acid insert within the prepropeptide, between -18(ala)|-17(val), in the short 38-amino acid form). Exon 6 codes for activation (splitting into L and H chains) domain, which the most variable one in the group of related proteins. Almost two thirds of exon 8 represent the 3'-utl (untranslated) region, which consists (after the stop codon tag/980 bp) poly(A) signal and at least three polyadenylation sites: dinucleotides t(c), c(a), and c(a) - 15, 19, and 41 bp, respectively, after poly(A) signal.
[2] Five regions (r1-r5, denoted  at the diagram) contain prolonged, tandem, imperfect minisatellite repeats (r1= 747 bp, r2= 871, r3= 894, r4= 222, r5= 364 bp). (r1-r4) take up 27% of the total length of introns; (r5) takes up 35.5% of the 3'-utl region length of exon 8. The monomer lengths in the satellites vary within 14-20 bp, number of copies in a tandem being 6-52. Polymorphism with respect to number of copies in r4, as well as periodicity of a higher order have been revealed (e.g., an 82 bp duplication in r3: monomers 12-15 are identical to monomers 41-44). In terms of the Stanford code, the consensus monomer (18 bp: cykcacncncjcaggdca) contains tetranucleotide , which is characteristic for many minisatellites."

FUN

Coagulation factor VII is a glycoprotein (vitamin K-dependent). It is synthesized in liver and secreted into the blood flow (its level being 100-500 ng/ml) as a single-stranded inactive protein (50 kD). Its convertion into an active form, VIIa, is catalyzed by other coagulation factors, IXa, Xa (both or one of them), XIIa, and thrombin (the external pathway of so called coagulation cascade). Factor VIIa, in the presence of membrane-bound thromboplastin (GEM:01p2/F3) and Ca ions, converts inactive factor X to the active form, Xa (the external and the internal cascade pathways meet at this stage). Moreover, complex VIIa+F3 activates factor X also indirectly, through the internal pathway, by participating in factor IX convertion into the active form, IXa (in the presence of Ca ions and factor XIa)."

MOP

[1] The primary translated peptide has two forms. They differ in the length of the N-terminal preproleader peptide (60 and 38 amino acid residues), which contain tetrapeptide Arg-Arg-Arg-Arg at the C-end and is splitted by signal peptidase at position -1,+1 (Arg-Ala). The mature inactive protein contains 406 amino acids. Activation (performed by proteases such as factor Xa) consists in the splitting of inactive factor VII at position 152-153 (Arg-Ile) with the formation of double-chained molecule of active VIIa.
[2] The light L-chain (1-152) contains 10 Glu in the N-terminal region (potential sites for vitamin K-dependent gamma-carboxylation), which form domain accounting for Ca-dependent interaction of factor VIIa with the complex F3-phospholipid. Two potential domains (cys-50...asp-86 and asp-87...cys-127) are likelt to account for the interaction with epidermal growth factor (GEM:04q25/EGF). Beta-hydroxyaspartate is found at position 63, that is typical for other related serine proteases. The potential glycosilation site is Asn-145.
[3] The heavy H-chain (30 kD, 254 amino acids, the N-end: Ile-Val-Gly-Gly..) contains in the middle part a catalytic (serine protease) region, including three amino acid residues that play a key role in catalysis (His-41, Asp-90, Ser-192), as well as potential glycosilation site, Asn-170.
[4] L- and H-chains form a disulfide link Cys(L/135)-Cys(H/110) analogous to that in other vitamin K-dependent proteins. The total MM of the two polypeptide chains is 45.5 kD; two carbohydrate chains (after L-,H-glycosilation) add 4.5 kD. The degree of homology with other serum proteins (prothrombin, factors IX and X, C protein) varies from 25 to 40%, that is the evidence in favor of their origin from a single ancestor gene."

FAG

It is possible that chr 8 contains a gene regulator (repressor) of F7 activity, as follows from the data on 50% decreased factor VII activity in several mosaics for trisomy 8 (see Reference in GEM:08p23/F7R)."

LIN

F7 gene is closely linked to F10 (GEM:13q34/F10).

PRO

[1] Probe 7M1 is a 12 kb EcoRI insert covering 85% of F7 gene 5'-part. The clone was obtained from the genomic library (in phage lambda Charon 4A).
[2]Probe 7DC1 is a 8 kb BamHI insert covering 80% of F7 gene 3'-part. The clone was obtained from the genomic library (in phage lambda L47.1)."

REF

HIS,PAT,FOG "Alexander &: J Clin Invest, 30, 596-?, 1951
PRO,SEQ,MOP "Berkner &: Cold Spring Harbor Symp, 51, (Part 1), 531-541, 1986
LOC,FAG "De Grouchy J &: Hum Genet, 66, 230-233, 1984
HIS,PAT,FOG "De Vries &: Blood, 4, 247-?, 1949
HIS,PAT,FOG "Dische, Benfield: Acta Haematol, 21, 257-?, 1959
FUN,MEB "Fay, Walker: BBA, 994, 142-148, 1989
PHE,MGC,CAG "Fukushima &: Jpn J Hum Genet, 32, 91-96, 1987
LOC,FAG "Gilgenkrantz &: Ann Genet, 29, 32-35, 1986
PRO,SEQ,MOP "Hagen FS &: PNAS, 83, N8, 2412-2416, 1986
HIS,PAT,FOG "Hougie &: J Clin Invest, 36, 485-?, 1957
HIS,PAT,FOG "Koller &: Acta Haematol, 6, 1-?, 1951
HIS,PAT,FOG "Kupfer &: Blood, 15, 146-163, 1960
HIS,PAT,FOG "Mann, Hurn: Am J Physiol, 164, 105-?, 1951
HIS,PAT,FOG "Marder, Shulman: Am J Med, 37, 182-194, 1964
PHE,MGC,CAG "Mariani &: Brit J Haematol, 48, 7-14, 1981
GEN,MOP,FAG "Murray &: NAR, 16, N9, 4166, 1988
GEN,MAF "O'Hara PJ, Grant: Gene, 66, 147-158, 1988
GEN,SEQ,EXP,PRO "O'Hara PJ &: PNAS, 84, N15, 5158-5162, 1987
LOC,FAG "Ott R, Pfeiffer: Hum Hered, 34, 123-126, 1984
HIS,PAT,FOG "Owren PA: Scand J Lab Invest, 3, 168-?, 1951
LOC,FAG "Pfeiffer RA &: Hum Genet, 69, N2, 192, 1985
LOC,FAG "Pfeiffer RA &: Hum Genet, 62, 358-360, 1982
PHE,MGC,CAG "Ragni &: Am J Hematol, 10, 79-88, 1981
FUN,MEB "Rao, Rapaport: PNAS, 85, N18, 6687-6691, 1988
HIS,PAT,FOG "Stefanini M: Am J Med, 14, 64-?, 1953
PHE,MGC,CAG "Triplett &: Blood, 66, 1284-1287, 1985
HIS,PAT,FOG "Voss, Waaler: Thromb Diath Haemorrah, 3, 375-?, 1959
HIS,PAT,FOG "Yoshioka &: J Nara Med Ass, 20, N6, 462-473, 1969

SWI

SWISSPROT: P08709

KEY

hem, clot

CLA

coding, basic

LOC

13 q34

MIM

MIM: 227500

EZN

ENZYME: 3.4.21.21

Ссылки: